Evidence map›Paper›PMID 29181196›Full record

ArticleInternational journal of molecular imaging2017

Virpi Tunninen, Pekka Varjo, Tomi Kauppinen, Anu Holm, Hannu Eskola, Marko Seppänen

Abstract read
In one paragraph

Article in International journal of molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Virpi TunninenDepartment of Nuclear Medicine, Satakunta Central Hospital, Sairaalantie 3, 28500 Pori, Finland.ORCID 0000-0002-2683-1000
Pekka VarjoDepartment of Nuclear Medicine, Satakunta Central Hospital, Sairaalantie 3, 28500 Pori, Finland.
Tomi KauppinenHelsinki University Hospital, HUS Medical Imaging Center, P.O. Box 340, 00029 Helsinki, Finland.
Anu HolmDepartment of Nuclear Medicine, Satakunta Central Hospital, Sairaalantie 3, 28500 Pori, Finland.ORCID 0000-0003-4282-6479
Hannu EskolaFaculty of Biomedical Sciences, Tampere University of Technology, P.O. Box 692, 33101 Tampere, Finland.
Marko SeppänenTurku PET Centre, Turku University Hospital, P.O. Box 52, 20521 Turku, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis retrospective study evaluated whether the use of additional anterior MATERIALS AND

methodsPS using simultaneous dual-isotope subtraction methods and an acquisition protocol combining SPECT/CT and planar pinhole imaging was performed for 175 patients with primary or secondary hyperparathyroidism. All patients who proceeded to surgery with complete postsurgery laboratory findings were included in this study (

resultsThere were 111 enlarged parathyroid glands of which 104 and 108 glands were correctly visualized by SPECT/CT (seven false positives) or SPECT/CT with pinhole (three false positives), respectively. Both sensitivity and specificity were higher with combined SPECT/CT with pinhole than with SPECT/CT alone (97% versus 94% and 99% versus 98%, resp., not significant). The false-positive rate was 6% with SPECT/CT and decreased to 3% using combined SPECT/CT with pinhole.

conclusion

Identifiers

PMID29181196
PMCPMC5664318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.